LADENBURG THALMANN FINANCIAL SERVICES INC. - CARDIOME PHARMA CORP ownership

CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 27 filers reported holding CARDIOME PHARMA CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of CARDIOME PHARMA CORP
ValueSharesWeighting
Q4 2015$20,000
-4.8%
2,5000.0%0.00%
Q3 2015$21,000
-12.5%
2,5000.0%0.00%
Q2 2015$24,000
+4.3%
2,5000.0%0.00%
Q1 2015$23,0000.0%2,5000.0%0.00%
-100.0%
Q4 2014$23,000
+4.5%
2,5000.0%0.00%0.0%
Q3 2014$22,000
+10.0%
2,5000.0%0.00%0.0%
Q2 2014$20,0000.0%2,5000.0%0.00%0.0%
Q1 2014$20,000
+233.3%
2,500
+150.0%
0.00%
Q4 2013$6,0001,0000.00%
Other shareholders
CARDIOME PHARMA CORP shareholders Q1 2016
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,918,722$6,006,0004.90%
Tamarack Advisers, LP 4,400,000$13,882,0002.18%
AlphaOne Investment Services, LLC 580,965$1,824,0000.60%
CLOUGH CAPITAL PARTNERS L P 3,061,064$9,581,0000.50%
Rock Springs Capital Management LP 1,200,000$3,751,0000.24%
TURNER INVESTMENTS LLC 150,000$470,0000.16%
WESTFIELD CAPITAL MANAGEMENT CO LP 5,397,007$16,893,0000.14%
SABBY MANAGEMENT, LLC 484,505$1,521,0000.06%
PUTNAM INVESTMENTS LLC 3,673,622$11,536,0000.03%
ARDSLEY ADVISORY PARTNERS LP 28,900$90,0000.01%
View complete list of CARDIOME PHARMA CORP shareholders